NEETPGAI
FeaturesNEET PGFMGEINI-CETBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • NEET PG Preparation
  • FMGE Preparation
  • INI-CET Preparation
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Myocardial Infarction Pathology
    Myocardial Infarction Pathology
    medium
    microscope Pathology

    A 58-year-old man presents to the emergency department with acute anterior wall myocardial infarction (STEMI) of 2 hours duration. He has no contraindications to fibrinolytic therapy and is in a non-PCI-capable hospital. Which is the drug of choice for immediate reperfusion therapy?

    A. Aspirin
    B. Metoprolol
    C. Alteplase
    D. Clopidogrel

    Explanation

    Fibrinolytic Therapy in STEMI

    Key Point
    Alteplase (tissue plasminogen activator, tPA) is the preferred fibrinolytic agent for acute STEMI in non-PCI-capable hospitals when primary PCI cannot be performed within 120 minutes of first medical contact.
    Mechanism of Action

    Alteplase is a recombinant tissue plasminogen activator that:

    • Directly activates plasminogen to plasmin
    • Exhibits fibrin-selectivity (preferentially binds to fibrin in thrombi)
    • Achieves TIMI 3 flow in ~50–60% of patients when given within 12 hours of symptom onset
    Dosing in Acute MI
    • Bolus: 15 mg IV over 1–2 minutes
    • Infusion: 0.75 mg/kg over 30 minutes (max 50 mg), then 0.5 mg/kg over 60 minutes (max 35 mg)
    • Total dose should not exceed 100 mg
    Comparison of Fibrinolytic Agents
    Table
    AgentFibrin-SelectivityTIMI 3 FlowBleeding RiskReperfusion Arrhythmia
    Alteplase (tPA)High50–60%ModerateCommon
    Reteplase (rPA)High60%ModerateCommon
    Tenecteplase (TNK)Very high65%LowerCommon
    StreptokinaseLow40–50%HigherCommon
    High-YieldNEET PG
    Alteplase is preferred in anterior MI and in patients <75 years with symptom onset <3 hours because it achieves superior patency rates compared to streptokinase.
    Clinical Pearl

    Reperfusion arrhythmias (accelerated idioventricular rhythm, ventricular tachycardia) indicate successful coronary recanalization and are a favorable prognostic sign.

    Contraindications to Fibrinolysis
    • Active internal bleeding
    • Recent intracranial hemorrhage or stroke (within 3 months)
    • Intracranial neoplasm or AVM
    • Severe uncontrolled hypertension (SBP >180 mmHg, DBP >110 mmHg)
    • Recent major surgery or trauma (within 2–4 weeks)
    Warning
    Do NOT confuse fibrinolytic choice with antiplatelet/anticoagulant adjuncts. Aspirin and clopidogrel are given alongside fibrinolysis, not instead of it.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →